Tonix Pharmaceuticals Holding Corp. (TNXP)
Oxford Ledge is still expanding full research coverage of TNXP. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Tonix commercializes fibromyalgia and migraine treatments while developing a pipeline of therapies for CNS disorders and other indications.
SEC filings
- 8-K Regulation FD disclosure; Other material event; Financial statements and exhibits 2026-07-13
- 8-K Regulation FD disclosure; Other material event; Financial statements and exhibits 2026-06-29
- 8-K Regulation FD disclosure; Other material event; Financial statements and exhibits 2026-06-08
- 8-K Regulation FD disclosure; Other material event; Financial statements and exhibits 2026-05-27
- 8-K Regulation FD disclosure; Other material event; Financial statements and exhibits 2026-05-15
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for TNXP. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open TNXP in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.